Stereotaxis, Inc.
Stereotaxis, Inc. is listed today as Stereotaxis, Inc.: market value, financials and filings are on its company page.
Funding rounds
0 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2024 | $3 M | Private placement after listing | $2 to $10 million | equity | SEC | |
| Aug 2019 | $25 M | Private placement after listing | $10 to $50 million | equity | SEC | |
| Sep 2016 | $24 M | Private placement after listing | $10 to $50 million | equity, options | SEC | |
| May 2012 | $8 M | Private placement after listing | $2 to $10 million | debt, options | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Stereotaxis, Inc., its revenue in fiscal 2025 came from these product and service lines: Disposables Service and Accessories $22.15 million (68%), Systems $10.22 million (32%).
Annual report (SEC XBRL) · Dec 2025
Stereotaxis, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2024).
SEC Form D · Aug 2024
The industry group it chose in its notices: Other Health Care.
SEC Form D · Aug 2024
Products and services#
No products or services of Stereotaxis, Inc. are on record.
Investors#
1 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| DAFNA Capital Management LLC | Fund or asset manager | not stated | not stated | Held Series A preferred stock, 10% owner (Form 3, 2018) | SEC Form 3 |
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete.
Largest shareholders today
Institutions holding Stereotaxis, Inc. shares, as of Sep 30, 2026.
- DAFNA Capital Management LLC$17 M13.65%
- BlackRock, Inc.$5 M4.38%
- Lagoda Investment Management, L.P.$5 M3.97%
- Vanguard Capital Management LLC$4 M3.00%
- Arbiter Partners Capital Management LLC$4 M2.88%
- Geode Capital Management, LLC$2 M1.90%
- Archon Capital Management LLC$2 M1.22%
- Warberg Asset Management LLC$1 M1.13%
- State Street Corp$1 M0.91%
- Integrity Alliance, LLC.$1 M0.70%
- AlphaCentric Advisors LLC$1 M0.60%
- Vanguard Fiduciary Trust Co$1 M0.59%
- Northern Trust Corp$1 M0.56%
- Bank Julius Baer & Co. Ltd, Zurich$1 M0.54%
- Vanguard Portfolio Management LLC$1 M0.48%
Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| David L. Fischel | Executive officer | Aug 2024 |
| Kimberly R. Peery | Executive officer | Aug 2024 |
| Kevin M. Barry | Executive officer | Aug 2019 |
| Martin C. Stammer | Executive officer | Aug 2019 |
| David A Giffin | Vice President, Human Resources. | Oct 2016 |
| Frank J. Cheng | Senior Vice President, Marketing and Business Development. | Oct 2016 |
| Karen Witte Duros | Sr. Vice President, General Counsel and Secretary. | Oct 2016 |
| Martin C Stammer | Chief Financial Officer. | Oct 2016 |
| Paul A. Brathwaite | Vice President, Research and Development. | Oct 2016 |
| William C. Mills III | Chairman of the Board and Chief Executive Officer. | Oct 2016 |
| David A. Giffen | Executive officer | May 2012 |
| Karen W. Duros | Executive officer | May 2012 |
| Michael P. Kaminski | Executive officer | May 2012 |
| Samuel W. Duggan | Executive officer | May 2012 |
| Arun S. Menawat | Director | Aug 2024 |
| David L. Fischel | Director | Aug 2024 |
| David W. Benfer | Director | Aug 2024 |
| Kimberly R. Peery | Director | Aug 2024 |
| Myriam W. Curet | Director | Aug 2024 |
| Nachum S. Shamir | Director | Aug 2024 |
| Nathan W. Fischel | Director | Aug 2024 |
| Ross B. Levin | Director | Aug 2024 |
| Joe W. Kiani | Director | Aug 2019 |
| Robert J. Messey | Director | Aug 2019 |
| Ross W. Levin | Director | Aug 2019 |
| Arun A Menawat | Director | Oct 2016 |
| David A Fischel | Director | Oct 2016 |
| Duane N DeSisto | Director | Oct 2016 |
| Eric N Prystowsky | Director | Oct 2016 |
| Fred A. Middleton | Director | Oct 2016 |
| Joseph A Kiani | Director | Oct 2016 |
| William C. Mills III | Chairman of the Board and Chief Executive Officer. | Oct 2016 |
| Christopher D. Alafi | Director | May 2012 |
| Eric N. Prystowsky | Director | May 2012 |
| Joseph D. Keegan | Director | May 2012 |
| Michael P. Kaminski | Director | May 2012 |
| William C. Mills | Director | May 2012 |
| William M. Kelley | Director | May 2012 |
Went public since 2011. Its SEC number is that of a company listed on a stock exchange.